Company Filing History:
Years Active: 2000
Title: James Christopher Mason: Innovator in Biochemical Research
Introduction
James Christopher Mason is a notable inventor based in San Diego, California. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for key metabolic enzymes. His work has implications for various therapeutic applications.
Latest Patents
James Christopher Mason holds a patent for "Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase)." This patent includes compounds of formula A, which are designed to inhibit the enzyme FBPase, potentially impacting metabolic pathways.
Career Highlights
Mason is associated with Ontogen Corporation, where he applies his expertise in biochemical research. His innovative approach has led to advancements in understanding metabolic regulation and its therapeutic potential.
Collaborations
Throughout his career, Mason has collaborated with talented individuals such as Adnan M Mjalli and Kristen Lee Arienti. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
James Christopher Mason's contributions to biochemical research and his innovative patent demonstrate his commitment to advancing science. His work continues to influence the field and offers promising avenues for future research and development.